Bottom line
Is MARB a good fund? The bottom line
MARB is an actively managed alternatives ETF from First Trust.
It charges 0.95% — about $95 a year on every $10,000 invested, cheaper than 81% of alternatives funds we track.
It returned +6.9% over one year, +2.8% a year over five years (as of Dec 31, 2025, per its prospectus).
With $16.3 million in net assets and 17 holdings, its largest position is Dreyfus Government Cash Management Funds (82.7%) and the top 10 make up 86.3% of the portfolio.
What stands out
- Low cost: cheaper than 81% of alternatives peers
What to watch
- 5-year return in the bottom quarter of its category
- Concentrated: top 10 holdings are 86.3% of assets
- Small fund ($16.3 million) — small funds are likelier to close
- High turnover (195% a year) can mean more taxable distributions
Updated Nov 19, 2026
What MARB invests in
The First Trust Equity Market Neutral ETFs (the Fund ) investment objective is to seek to provide investors with capital appreciation.
Under normal market conditions, the Fund seeks to invest at least 80% of its net assets (plus any borrowings for investment purposes) in derivative instruments (exchange-traded or over-the-counter) that provide exposure to U.S exchange-listed equity securities, U.S. exchange-traded funds ( ETFs ) that provide exposure to U.S. exchange-listed equity securities (directly or through derivatives) and/or U.S. exchange-listed equity securities. For purposes of compliance with this investment policy, derivative contracts will be valued at their gross notional value. The Fund seeks an equity market neutral approach where the overall performance of the Fund is driven primarily by the net performance of long and short positions, independent of directional movements in the market. The Fund expects to maintain long and short positions primarily through the use of total return swaps. The Fund may…
From the fund's prospectus (filed Jun 18, 2026).
MARB performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MARB | +6.9% | +2.8% | — |
| Alternatives median | +7.4% | +4.2% | +3.8% |
Source: Fund prospectus, as of Dec 31, 2025
What MARB costs
On a $10,000 investment, MARB's 0.95% expense ratio costs about $95 a year. The median alternatives fund charges 1.54%.
MARB top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Dreyfus Government Cash Management Funds | 82.74% |
| 2 | Morgan Stanley Institutional Liquidity Funds | 0.87% |
| 3 | Bnp Paribas | 0.82% |
| 4 | Citigroup Inc. | 0.58% |
| 5 | Citigroup Inc. | 0.53% |
| 6 | Bnp Paribas | 0.49% |
| 7 | Jpmorgan Chase Bank, National Association | 0.22% |
| 8 | Paragon 28 Inc | 0.00% |
| 9 | Icosavax Inc | 0.00% |
| 10 | Chinook Therapeutics Inc | 0.00% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 86.3% of the fund. See all top 25 holdings and asset mix →